Trials / Conditions / Acral Lentiginous Malignant Melanoma
Acral Lentiginous Malignant Melanoma
5 registered clinical trials studyying Acral Lentiginous Malignant Melanoma.
| Status | Trial | Sponsor | Phase |
|---|---|---|---|
| Terminated | Gamma-Secretase/Notch Signalling Pathway Inhibitor RO4929097 in Treating Patients With Stage IV Melanoma NCT01120275 | National Cancer Institute (NCI) | Phase 2 |
| Completed | A Trial Looking at Nilotinib to Treat Acral and Mucosal Melanoma Skin Cancer That Has Spread NCT01395121 | Institute of Cancer Research, United Kingdom | Phase 2 |
| Completed | SU011248 in Patients With Metastatic Mucosal or Acral/Lentiginous Melanoma NCT00577382 | Dana-Farber Cancer Institute | Phase 2 |
| Completed | Imatinib Mesylate in Treating Patients With Stage III or Stage IV Melanoma That Cannot Be Removed by Surgery NCT00470470 | National Cancer Institute (NCI) | Phase 2 |
| Completed | AZD2171 in Treating Patients With Recurrent or Stage IV Melanoma NCT00243061 | National Cancer Institute (NCI) | Phase 2 |